A Retrospective Study of Cardiovascular Events Related to the Use of Glucose Lowering Drug Treatment in Primary Care — ROSE

Diabetes Type II Clinical Trial

Official title:
A Retrospective Epidemiological Study to Investigate Outcome and Mortality With Glucose Lowering Drug Treatment in Primary Care

Status Completed

Clinical Trial Summary

To describe the type II diabetes population in primary care with special reference to treatment, other diseases and mortality during the last decade. To test the hypothesis that the type or combination of per oral glucose lowering drugs have different effects on the risk of cardiovascular disease and diabetic complications.

Clinical Trial Description

n/a

Study Design

Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01121315
Study type	Observational
Source	AstraZeneca
Contact
Status	Completed
Phase	N/A
Start date	May 2010
Completion date	August 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01713764` - A Pilot Study of the Effects of Diet and Behavioral Interventions on Health in Diabetics	Phase 2
Completed	`NCT02773095` - Evaluation of Novartis Access; a Non-communicable Disease (NCD) Access Initiative	N/A
Completed	`NCT02184455` - Feasibility Study of DermGEN for Diabetic Foot Ulcer Treatment	Phase 1
Recruiting	`NCT02361489` - Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go ® in Patients With Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care Offices	Phase 4
Completed	`NCT02326129` - Novel Biomarker for Development of T2D
Not yet recruiting	`NCT02074540` - The Influence of Health Beliefs and Uncertainty on Diabetes Type II Patient Compliance	N/A